Jade Biosciences (JBIO) Property, Plant & Equipment (Net) (2020 - 2026)

Jade Biosciences (JBIO) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn - 642,333.36
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.27 Bn 467.47 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.18 Bn 114.93 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.08 Bn 61.32 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn 518.26 Mn
10 Jade Biosciences 1.18 Bn 871.69 Mn - 157,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 157,000.00
Mar 31, 2026 157,000.00
Dec 31, 2025 170,000.00
Dec 31, 2025 170,000.00
Sep 30, 2025 176,000.00
Sep 30, 2025 176,000.00
Jun 30, 2025 147,000.00
Jun 30, 2025 147,000.00
Mar 31, 2025 2,000.00
Mar 31, 2025 2,000.00
Sep 30, 2024 14,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 232,000.00
Jun 30, 2024 232,000.00
Mar 31, 2024 260,000.00
Mar 31, 2024 260,000.00
Dec 31, 2023 288,000.00
Dec 31, 2023 288,000.00
Sep 30, 2023 316,000.00
Sep 30, 2023 316,000.00